» Articles » PMID: 16443764

Effects of Type 1 Diabetes on Gray Matter Density As Measured by Voxel-based Morphometry

Overview
Journal Diabetes
Specialty Endocrinology
Date 2006 Jan 31
PMID 16443764
Citations 123
Authors
Affiliations
Soon will be listed here.
Abstract

The effects of type 1 diabetes and key metabolic variables on brain structure are not well understood. Sensitive methods of assessing brain structure, such as voxel-based morphometry (VBM), have not previously been used to investigate central nervous system changes in a diabetic population. Using VBM, we compared type 1 diabetic patients aged 25-40 years with disease duration of 15-25 years and minimal diabetes complications with an age-matched, nondiabetic control group. We investigated whether lower than expected gray matter densities were present, and if so, whether they were associated with glycemic control and history of severe hypoglycemic events. In comparison with control subjects, diabetic patients showed lower density of gray matter in several brain regions. Moreover, in the patient group, higher HbA(1c) levels and severe hypoglycemic events were associated with lower density of gray matter in brain regions responsible for language processing and memory. Our study represents the first comprehensive study of gray matter density changes in type 1 diabetes and suggests that persistent hyperglycemia and acute severe hypoglycemia have an impact on brain structure.

Citing Articles

Cerebral Small Vessel Disease Is Associated With Smaller Brain Volumes in Adults With Type 1 Diabetes.

Claesson T, Putaala J, Shams S, Salli E, Gordin D, Mutter S J Diabetes Res. 2024; 2024:5525213.

PMID: 38984211 PMC: 11233188. DOI: 10.1155/2024/5525213.


The clinical features and potential mechanisms of cognitive disorders in peripheral autoimmune and inflammatory diseases.

Fan K, Huang T, Yu J, Li Y, Jin J Fundam Res. 2024; 4(2):226-236.

PMID: 38933510 PMC: 11197673. DOI: 10.1016/j.fmre.2022.12.005.


Longitudinal Progression of White Matter Hyperintensity Severity in Chronic Stroke Aphasia.

Busby N, Newman-Norlund R, Wilmskoetter J, Johnson L, Rorden C, Gibson M Arch Rehabil Res Clin Transl. 2024; 5(4):100302.

PMID: 38163020 PMC: 10757197. DOI: 10.1016/j.arrct.2023.100302.


Patterns of Regional Brain Atrophy and Brain Aging in Middle- and Older-Aged Adults With Type 1 Diabetes.

Habes M, Jacobson A, Braffett B, Rashid T, Ryan C, Shou H JAMA Netw Open. 2023; 6(6):e2316182.

PMID: 37261829 PMC: 10236234. DOI: 10.1001/jamanetworkopen.2023.16182.


Diabetes, brain health, and treatment gains in post-stroke aphasia.

Roth R, Busby N, Wilmskoetter J, Schwen Blackett D, Gleichgerrcht E, Johnson L Cereb Cortex. 2023; 33(13):8557-8564.

PMID: 37139636 PMC: 10321080. DOI: 10.1093/cercor/bhad140.